ADMA Biologics, Inc.

You are now leaving www.admabiologics.com

The link you have selected will take you outside of ADMA Biologics corporate website. The site you will be entering is intended for U.S. audiences only. Do you wish to continue?

Yes No

About ADMA Biologics

A Commercial Biopharmaceutical Company with End-to-End Control of Critical Manufacturing Functions

ADMA Biologics is an end-to-end commercial biopharmaceutical company committed to manufacturing, marketing, and developing specialty plasma-derived products for the prevention and treatment of infectious diseases in the immune compromised and other patients at risk for infection. Our devotion to these underserved populations fuels us, and our hands-on approach to production and development sets us apart.

With three FDA-licensed approved products, including ASCENIV™ (Immune Globulin Intravenous, Human – slra), BIVIGAM® (Immune Globulin Intravenous, Human), and NABI-HB® (Hepatitis B Immune Globulin, Human), ADMA’s mission is to continue to successfully develop and commercialize plasma-derived, human immune globulins targeted to niche patient populations for the treatment and prevention of certain infectious diseases and management of immune compromised patient populations.

ADMA Biologics is the only US-domiciled producer of plasma-derived therapeutics

ADMA Biologics is the only US-domiciled producer of plasma-derived therapeutics
  • Rapidly growing and diversified commercial product portfolio and CDMO platform
  • Strong patent portfolio supports pipeline optionality and long-term growth opportunities
  • World class, cGMP-compliant biologics manufacturing plant with up to ~600,000L annual plasma fractionation and purification capacity
  • End-to-end supply chain control, including fill-finish capabilities supporting internal production and external CDMO opportunities
  • Advancing toward raw material plasma supply self-sufficiency with 10 plasma collection centers under corporate umbrella

  • Three FDA approved products: ASCENIV™ (Immune Globulin Intravenous, Human – slra), BIVIGAM® (Immune Globulin Intravenous, Human) and Nabi-HB® (Hepatitis B Immune Globulin, Human)

  • Thought leader in the development and commercialization of Hyperimmune IG products
  • Consistent, reliable, and uninterrupted raw material supply


Through our relentless commitment to improving patients' lives, we are changing the future with immunotechnology.

 

View our Video to Learn More